Keen Eye Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

Keen Eye General Information

Description

Developer of AI-powered image analysis platform designed to guide better drug development and diagnostics. The company's technology permits doctors and biologists to reproduce and extend their visual expertise, notably by identifying signals with a high predictive value that are difficult to detect, and analyzing tissue samples across any therapeutic area, enabling medical practitioners to save valuable time in day-to-day decision-making.

Contact Information

Website
www.keeneye.ai
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 74 Rue Du Faubourg Saint-Antoine
  • 75012 Paris
  • France
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Healthcare Services
Acquirer
Corporate Office
  • 74 Rue Du Faubourg Saint-Antoine
  • 75012 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keen Eye Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 01-Jan-2023 Completed Generating Revenue
8. Later Stage VC 31-Dec-2019 Completed Generating Revenue
7. Later Stage VC (Series A) 29-Apr-2019 Completed Generating Revenue
6. Seed Round 12-Dec-2016 Completed Generating Revenue
5. Angel (individual) 15-Jun-2016 Completed Startup
4. Angel (individual) 01-Dec-2015 Completed Startup
3. Angel (individual) 23-May-2015 Completed Startup
2. Angel (individual) 26-Dec-2014 $142K $142K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Keen Eye’s complete valuation and funding history, request access »

Keen Eye Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P-2020 Shares
P-2019 Shares
P-2016 Shares
O Shares
O Shares
O Shares 900 $0.011107 $34.12 $34.12 1x $34.12 0.26%
O Shares 3,800 $0.011107 $33.6 $33.6 1x $33.6 1.11%
To view Keen Eye’s complete cap table history, request access »

Keen Eye Patents

Keen Eye Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021094507-A1 Method for analysis of a cytology image Inactive 13-Nov-2019
EP-3593320-A1 Automated reconstruction method of filament network Inactive 07-Mar-2017
WO-2018162572-A1 Automated reconstruction method of filament network Inactive 07-Mar-2017
WO-2018162941-A1 Automated reconstruction method of filament network Inactive 07-Mar-2017
EP-3479339-A1 Multimodal viewer Active 30-Jun-2016 G06T1/60
To view Keen Eye’s complete patent history, request access »

Keen Eye Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keen Eye Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Crédit Mutuel Equity Growth/Expansion Minority
Seventure Venture Capital Minority
To view Keen Eye’s complete investors history, request access »

Keen Eye FAQs

  • When was Keen Eye founded?

    Keen Eye was founded in 2013.

  • Where is Keen Eye headquartered?

    Keen Eye is headquartered in Paris, France.

  • What is the size of Keen Eye?

    Keen Eye has 21 total employees.

  • What industry is Keen Eye in?

    Keen Eye’s primary industry is Discovery Tools (Healthcare).

  • Is Keen Eye a private or public company?

    Keen Eye is a Private company.

  • What is Keen Eye’s current revenue?

    The current revenue for Keen Eye is .

  • How much funding has Keen Eye raised over time?

    Keen Eye has raised $12M.

  • Who are Keen Eye’s investors?

    Crédit Mutuel Equity and Seventure have invested in Keen Eye.

  • When was Keen Eye acquired?

    Keen Eye was acquired on 01-Jan-2023.

  • Who acquired Keen Eye?

    Keen Eye was acquired by Tribun Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process